NCT03068910 2025-08-05
CRM008
University of Virginia
Phase EARLY_PHASE1 Recruiting
Clinical Trials
9 trialsNCT04723862 2025-08-05
CBS010
University of Virginia
Phase EARLY_PHASE1 Recruiting
NCT05394142 2024-04-22
SPIOMET4HEALTH
Fundació Sant Joan de Déu
Phase 2 Recruiting
NCT01422759 2023-10-27
Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess
University of Virginia
Phase NA Unknown
NCT04075149 2023-10-27
CBS009
University of Virginia
Phase EARLY_PHASE1 Unknown
NCT02689843 2019-11-12
AntiPCO
Shiraz University of Medical Sciences
Phase EARLY_PHASE1 Completed
NCT01526616 2012-02-06
Spironolactone Plus Metformin in Polycystic Ovary Syndrome
University Magna Graecia
Phase NA Completed
NCT00842140 2010-07-22
Safety of Hormonal Contraceptives Therapies in Polycystic Ovary Syndrome (PCOS) Women
University of Sao Paulo
Phase NA Completed
NCT00004311 2005-06-24
Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome
Office of Rare Diseases (ORD)
Phase 2 Completed